APO Research
Talk to an analyst

APO RESEARCH · REPORT

Panic Attack Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Panic Attack Treatment Industry Growth and Trends Forecast to 2032

31 December 2025101 pages

Choose your research edition.

Industry ResearchPanic Attack Treatment Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Panic Attack Treatment Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Panic Attack Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Panic Attack Treatment Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Panic Attack Treatment Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

According to APO Research, the global Panic Attack Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Panic Attack Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Panic Attack Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Panic Attack Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Panic Attack Treatment market include Noven Pharmaceuticals, Inc., Recordati Rare Diseases(Recordati), Actavis Generics, Bristol Myers Squibb(BMS), Baxter International Inc., Sumitomo Dainippon Pharma, GlaxoSmithKline plc., Pfizer,Inc. and Eli Lilly and Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Panic Attack Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Panic Attack Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Panic Attack Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Panic Attack Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Panic Attack Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Panic Attack Treatment Market by Company

Noven Pharmaceuticals, Inc.

Recordati Rare Diseases(Recordati)

Actavis Generics

Bristol Myers Squibb(BMS)

Baxter International Inc.

Sumitomo Dainippon Pharma

GlaxoSmithKline plc.

Pfizer,Inc.

Eli Lilly and Company

F. Hoffmann-La Roche Ltd

Abbott Laboratories

Shionogi & Co., Ltd.

Panic Attack Treatment Segment by Type

Selective Serotonin Reuptake Inhibitor(SSRI)

Benzodiazepines(BZD)

Serotonin Norepinephrine Reuptake Inhibitor(SNRI)

Panic Attack Treatment Segment by Application

Hospitals

Mental Healthcare Centers

Others

Panic Attack Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Panic Attack Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Panic Attack Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Panic Attack Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Panic Attack Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Panic Attack Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Panic Attack Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Panic Attack Treatment Market Share by Region (2021-2026) Table 4. Global Panic Attack Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Panic Attack Treatment Market Share by Region (2027-2032) Table 6. Global Panic Attack Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Panic Attack Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Panic Attack Treatment Market Size Share by Type (2021-2026) Table 9. Global Panic Attack Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Panic Attack Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Panic Attack Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Panic Attack Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Panic Attack Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Panic Attack Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Panic Attack Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Panic Attack Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Panic Attack Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Panic Attack Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Panic Attack Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Panic Attack Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Panic Attack Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Panic Attack Treatment Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Panic Attack Treatment Market Size Share by Application (2021-2026) Table 24. Global Panic Attack Treatment Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Panic Attack Treatment Market Size Share Forecasted by Application (2027-2032) Table 26. North America Panic Attack Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Panic Attack Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Panic Attack Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Panic Attack Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Panic Attack Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Panic Attack Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Panic Attack Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Panic Attack Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Panic Attack Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Panic Attack Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Panic Attack Treatment Industry Trends Table 37. Panic Attack Treatment Industry Drivers Table 38. Panic Attack Treatment Industry Opportunities and Challenges Table 39. Panic Attack Treatment Industry Restraints Table 40. Global Panic Attack Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Panic Attack Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Panic Attack Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Panic Attack Treatment Key Company Headquarters & Area Served Table 44. Global Panic Attack Treatment Company, Product Type & Application Table 45. Global Panic Attack Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Panic Attack Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Noven Pharmaceuticals, Inc. Company Information Table 49. Noven Pharmaceuticals, Inc. Business Overview Table 50. Noven Pharmaceuticals, Inc. Panic Attack Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Noven Pharmaceuticals, Inc. Panic Attack Treatment Product Portfolio Table 52. Noven Pharmaceuticals, Inc. Recent Development Table 53. Recordati Rare Diseases(Recordati) Company Information Table 54. Recordati Rare Diseases(Recordati) Business Overview Table 55. Recordati Rare Diseases(Recordati) Panic Attack Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Recordati Rare Diseases(Recordati) Panic Attack Treatment Product Portfolio Table 57. Recordati Rare Diseases(Recordati) Recent Development Table 58. Actavis Generics Company Information Table 59. Actavis Generics Business Overview Table 60. Actavis Generics Panic Attack Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Actavis Generics Panic Attack Treatment Product Portfolio Table 62. Actavis Generics Recent Development Table 63. Bristol Myers Squibb(BMS) Company Information Table 64. Bristol Myers Squibb(BMS) Business Overview Table 65. Bristol Myers Squibb(BMS) Panic Attack Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Bristol Myers Squibb(BMS) Panic Attack Treatment Product Portfolio Table 67. Bristol Myers Squibb(BMS) Recent Development Table 68. Baxter International Inc. Company Information Table 69. Baxter International Inc. Business Overview Table 70. Baxter International Inc. Panic Attack Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Baxter International Inc. Panic Attack Treatment Product Portfolio Table 72. Baxter International Inc. Recent Development Table 73. Sumitomo Dainippon Pharma Company Information Table 74. Sumitomo Dainippon Pharma Business Overview Table 75. Sumitomo Dainippon Pharma Panic Attack Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Sumitomo Dainippon Pharma Panic Attack Treatment Product Portfolio Table 77. Sumitomo Dainippon Pharma Recent Development Table 78. GlaxoSmithKline plc. Company Information Table 79. GlaxoSmithKline plc. Business Overview Table 80. GlaxoSmithKline plc. Panic Attack Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. GlaxoSmithKline plc. Panic Attack Treatment Product Portfolio Table 82. GlaxoSmithKline plc. Recent Development Table 83. Pfizer,Inc. Company Information Table 84. Pfizer,Inc. Business Overview Table 85. Pfizer,Inc. Panic Attack Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Pfizer,Inc. Panic Attack Treatment Product Portfolio Table 87. Pfizer,Inc. Recent Development Table 88. Eli Lilly and Company Company Information Table 89. Eli Lilly and Company Business Overview Table 90. Eli Lilly and Company Panic Attack Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Eli Lilly and Company Panic Attack Treatment Product Portfolio Table 92. Eli Lilly and Company Recent Development Table 93. F. Hoffmann-La Roche Ltd Company Information Table 94. F. Hoffmann-La Roche Ltd Business Overview Table 95. F. Hoffmann-La Roche Ltd Panic Attack Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. F. Hoffmann-La Roche Ltd Panic Attack Treatment Product Portfolio Table 97. F. Hoffmann-La Roche Ltd Recent Development Table 98. Abbott Laboratories Company Information Table 99. Abbott Laboratories Business Overview Table 100. Abbott Laboratories Panic Attack Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Abbott Laboratories Panic Attack Treatment Product Portfolio Table 102. Abbott Laboratories Recent Development Table 103. Shionogi & Co., Ltd. Company Information Table 104. Shionogi & Co., Ltd. Business Overview Table 105. Shionogi & Co., Ltd. Panic Attack Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Shionogi & Co., Ltd. Panic Attack Treatment Product Portfolio Table 107. Shionogi & Co., Ltd. Recent Development Table 108. North America Panic Attack Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America Panic Attack Treatment Market Size by Country (2021-2026) & (US$ Million) Table 110. North America Panic Attack Treatment Market Share by Country (2021-2026) Table 111. North America Panic Attack Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America Panic Attack Treatment Market Share Forecast by Country (2027-2032) Table 113. Europe Panic Attack Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Panic Attack Treatment Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Panic Attack Treatment Market Share by Country (2021-2026) Table 116. Europe Panic Attack Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Panic Attack Treatment Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Panic Attack Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Panic Attack Treatment Market Size by Country (2021-2026) & (US$ Million) Table 120. Asia-Pacific Panic Attack Treatment Market Share by Country (2021-2026) Table 121. Asia-Pacific Panic Attack Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Asia-Pacific Panic Attack Treatment Market Share Forecast by Country (2027-2032) Table 123. Latin America Panic Attack Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Latin America Panic Attack Treatment Market Size by Country (2021-2026) & (US$ Million) Table 125. Latin America Panic Attack Treatment Market Share by Country (2021-2026) Table 126. Latin America Panic Attack Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Latin America Panic Attack Treatment Market Share Forecast by Country (2027-2032) Table 128. Middle East & Africa Panic Attack Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Middle East & Africa Panic Attack Treatment Market Size by Country (2021-2026) & (US$ Million) Table 130. Middle East & Africa Panic Attack Treatment Market Share by Country (2021-2026) Table 131. Middle East & Africa Panic Attack Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Middle East & Africa Panic Attack Treatment Market Share Forecast by Country (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Panic Attack Treatment Product Image Figure 3. Global Panic Attack Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Panic Attack Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Panic Attack Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Panic Attack Treatment Market Share by Region (2021-2032) Figure 7. North America Panic Attack Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Panic Attack Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Panic Attack Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Panic Attack Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Panic Attack Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Selective Serotonin Reuptake Inhibitor(SSRI) Image Figure 13. Global Selective Serotonin Reuptake Inhibitor(SSRI) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Benzodiazepines(BZD) Image Figure 15. Global Benzodiazepines(BZD) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Serotonin Norepinephrine Reuptake Inhibitor(SNRI) Image Figure 17. Global Serotonin Norepinephrine Reuptake Inhibitor(SNRI) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Panic Attack Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Panic Attack Treatment Market Share by Type 2025 VS 2032 Figure 20. North America Panic Attack Treatment Market Size Share by Type (2021-2032) Figure 21. Europe Panic Attack Treatment Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Panic Attack Treatment Market Size Share by Type (2021-2032) Figure 23. Latin America Panic Attack Treatment Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Panic Attack Treatment Market Size Share by Type (2021-2032) Figure 25. Hospitals Image Figure 26. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Mental Healthcare Centers Image Figure 28. Global Mental Healthcare Centers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Others Image Figure 30. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Panic Attack Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Panic Attack Treatment Market Share by Application 2025 VS 2032 Figure 33. North America Panic Attack Treatment Market Size Share by Application (2021-2032) Figure 34. Europe Panic Attack Treatment Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Panic Attack Treatment Market Size Share by Application (2021-2032) Figure 36. Latin America Panic Attack Treatment Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Panic Attack Treatment Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Panic Attack Treatment Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Panic Attack Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Panic Attack Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Panic Attack Treatment Market Share by Country (2021-2032) Figure 43. Europe Panic Attack Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Panic Attack Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Panic Attack Treatment Market Share by Country (2021-2032) Figure 46. Asia-Pacific Panic Attack Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Panic Attack Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Panic Attack Treatment Market Share by Country (2021-2032) Figure 49. Latin America Panic Attack Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Panic Attack Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Panic Attack Treatment Market Share by Country (2021-2032) Figure 52. Middle East & Africa Panic Attack Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Panic Attack Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Panic Attack Treatment Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Selective Serotonin Reuptake Inhibitor(SSRI)
  • Benzodiazepines(BZD)
  • Serotonin Norepinephrine Reuptake Inhibitor(SNRI)
Applications
  • Hospitals
  • Mental Healthcare Centers
  • Others
Companies covered
  • Noven Pharmaceuticals, Inc.
  • Recordati Rare Diseases(Recordati)
  • Actavis Generics
  • Bristol Myers Squibb(BMS)
  • Baxter International Inc.
  • Sumitomo Dainippon Pharma
  • GlaxoSmithKline plc.
  • Pfizer,Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Shionogi & Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Panic Attack Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Panic Attack Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Panic Attack Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Panic Attack Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Panic Attack Treatment Market Size (2021-2032)
  8. 1.5.1 North America Panic Attack Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Panic Attack Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Panic Attack Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Panic Attack Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Panic Attack Treatment Market Size Growth Rate (2021-2032)
2 Panic Attack Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Selective Serotonin Reuptake Inhibitor(SSRI)
  3. 2.1.2 Benzodiazepines(BZD)
  4. 2.1.3 Serotonin Norepinephrine Reuptake Inhibitor(SNRI)
  5. 2.2 Global Panic Attack Treatment Market Size by Type
  6. 2.2.1 Global Panic Attack Treatment Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Panic Attack Treatment Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Panic Attack Treatment Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Panic Attack Treatment Market Size by Regions
  10. 2.3.1 North America Panic Attack Treatment Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Panic Attack Treatment Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Panic Attack Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Panic Attack Treatment Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Panic Attack Treatment Market Size Breakdown by Type (2021-2026)
3 Panic Attack Treatment Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospitals
  3. 3.1.2 Mental Healthcare Centers
  4. 3.1.3 Others
  5. 3.2 Global Panic Attack Treatment Market Size by Application
  6. 3.2.1 Global Panic Attack Treatment Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Panic Attack Treatment Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Panic Attack Treatment Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Panic Attack Treatment Market Size by Regions
  10. 3.3.1 North America Panic Attack Treatment Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Panic Attack Treatment Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Panic Attack Treatment Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Panic Attack Treatment Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Panic Attack Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Panic Attack Treatment Industry Trends
  2. 4.2 Panic Attack Treatment Industry Drivers
  3. 4.3 Panic Attack Treatment Industry Opportunities and Challenges
  4. 4.4 Panic Attack Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Panic Attack Treatment Revenue (2021-2026)
  2. 5.2 Global Panic Attack Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Panic Attack Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Panic Attack Treatment Company, Product Type & Application
  5. 5.5 Global Panic Attack Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Panic Attack Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Panic Attack Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Panic Attack Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Noven Pharmaceuticals, Inc.
  2. 6.1.1 Noven Pharmaceuticals, Inc. Company Information
  3. 6.1.2 Noven Pharmaceuticals, Inc. Business Overview
  4. 6.1.3 Noven Pharmaceuticals, Inc. Panic Attack Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Noven Pharmaceuticals, Inc. Panic Attack Treatment Product Portfolio
  6. 6.1.5 Noven Pharmaceuticals, Inc. Recent Developments
  7. 6.2 Recordati Rare Diseases(Recordati)
  8. 6.2.1 Recordati Rare Diseases(Recordati) Company Information
  9. 6.2.2 Recordati Rare Diseases(Recordati) Business Overview
  10. 6.2.3 Recordati Rare Diseases(Recordati) Panic Attack Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Recordati Rare Diseases(Recordati) Panic Attack Treatment Product Portfolio
  12. 6.2.5 Recordati Rare Diseases(Recordati) Recent Developments
  13. 6.3 Actavis Generics
  14. 6.3.1 Actavis Generics Company Information
  15. 6.3.2 Actavis Generics Business Overview
  16. 6.3.3 Actavis Generics Panic Attack Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Actavis Generics Panic Attack Treatment Product Portfolio
  18. 6.3.5 Actavis Generics Recent Developments
  19. 6.4 Bristol Myers Squibb(BMS)
  20. 6.4.1 Bristol Myers Squibb(BMS) Company Information
  21. 6.4.2 Bristol Myers Squibb(BMS) Business Overview
  22. 6.4.3 Bristol Myers Squibb(BMS) Panic Attack Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Bristol Myers Squibb(BMS) Panic Attack Treatment Product Portfolio
  24. 6.4.5 Bristol Myers Squibb(BMS) Recent Developments
  25. 6.5 Baxter International Inc.
  26. 6.5.1 Baxter International Inc. Company Information
  27. 6.5.2 Baxter International Inc. Business Overview
  28. 6.5.3 Baxter International Inc. Panic Attack Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Baxter International Inc. Panic Attack Treatment Product Portfolio
  30. 6.5.5 Baxter International Inc. Recent Developments
  31. 6.6 Sumitomo Dainippon Pharma
  32. 6.6.1 Sumitomo Dainippon Pharma Company Information
  33. 6.6.2 Sumitomo Dainippon Pharma Business Overview
  34. 6.6.3 Sumitomo Dainippon Pharma Panic Attack Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Sumitomo Dainippon Pharma Panic Attack Treatment Product Portfolio
  36. 6.6.5 Sumitomo Dainippon Pharma Recent Developments
  37. 6.7 GlaxoSmithKline plc.
  38. 6.7.1 GlaxoSmithKline plc. Company Information
  39. 6.7.2 GlaxoSmithKline plc. Business Overview
  40. 6.7.3 GlaxoSmithKline plc. Panic Attack Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline plc. Panic Attack Treatment Product Portfolio
  42. 6.7.5 GlaxoSmithKline plc. Recent Developments
  43. 6.8 Pfizer,Inc.
  44. 6.8.1 Pfizer,Inc. Company Information
  45. 6.8.2 Pfizer,Inc. Business Overview
  46. 6.8.3 Pfizer,Inc. Panic Attack Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer,Inc. Panic Attack Treatment Product Portfolio
  48. 6.8.5 Pfizer,Inc. Recent Developments
  49. 6.9 Eli Lilly and Company
  50. 6.9.1 Eli Lilly and Company Company Information
  51. 6.9.2 Eli Lilly and Company Business Overview
  52. 6.9.3 Eli Lilly and Company Panic Attack Treatment Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Eli Lilly and Company Panic Attack Treatment Product Portfolio
  54. 6.9.5 Eli Lilly and Company Recent Developments
  55. 6.10 F. Hoffmann-La Roche Ltd
  56. 6.10.1 F. Hoffmann-La Roche Ltd Company Information
  57. 6.10.2 F. Hoffmann-La Roche Ltd Business Overview
  58. 6.10.3 F. Hoffmann-La Roche Ltd Panic Attack Treatment Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 F. Hoffmann-La Roche Ltd Panic Attack Treatment Product Portfolio
  60. 6.10.5 F. Hoffmann-La Roche Ltd Recent Developments
  61. 6.11 Abbott Laboratories
  62. 6.11.1 Abbott Laboratories Company Information
  63. 6.11.2 Abbott Laboratories Business Overview
  64. 6.11.3 Abbott Laboratories Panic Attack Treatment Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Abbott Laboratories Panic Attack Treatment Product Portfolio
  66. 6.11.5 Abbott Laboratories Recent Developments
  67. 6.12 Shionogi & Co., Ltd.
  68. 6.12.1 Shionogi & Co., Ltd. Company Information
  69. 6.12.2 Shionogi & Co., Ltd. Business Overview
  70. 6.12.3 Shionogi & Co., Ltd. Panic Attack Treatment Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Shionogi & Co., Ltd. Panic Attack Treatment Product Portfolio
  72. 6.12.5 Shionogi & Co., Ltd. Recent Developments
7 North America
  1. 7.1 North America Panic Attack Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Panic Attack Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Panic Attack Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Panic Attack Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Panic Attack Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Panic Attack Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Panic Attack Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Panic Attack Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Panic Attack Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Panic Attack Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Panic Attack Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Panic Attack Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Panic Attack Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Panic Attack Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Panic Attack Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst